PSI Advisors LLC cut its position in The Procter & Gamble Company (NYSE:PG – Free Report) by 8.2% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 3,201 shares of the company’s stock after selling 285 shares during the period. PSI Advisors LLC’s holdings in Procter & Gamble were worth $537,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently made changes to their positions in the company. Traveka Wealth LLC lifted its holdings in shares of Procter & Gamble by 178.1% during the fourth quarter. Traveka Wealth LLC now owns 9,882 shares of the company’s stock valued at $1,657,000 after purchasing an additional 6,328 shares in the last quarter. BCS Wealth Management purchased a new position in Procter & Gamble in the 4th quarter worth about $1,877,000. Granite Bay Wealth Management LLC bought a new position in Procter & Gamble during the 4th quarter valued at about $347,000. First Financial Corp IN boosted its holdings in shares of Procter & Gamble by 4.1% during the 4th quarter. First Financial Corp IN now owns 11,555 shares of the company’s stock valued at $1,937,000 after acquiring an additional 453 shares during the last quarter. Finally, PFW Advisors LLC bought a new stake in shares of Procter & Gamble in the fourth quarter worth approximately $2,656,000. Institutional investors own 65.77% of the company’s stock.
Procter & Gamble Stock Up 0.2 %
NYSE PG opened at $158.86 on Tuesday. The Procter & Gamble Company has a 12 month low of $146.28 and a 12 month high of $180.43. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. The stock has a market cap of $374.12 billion, a PE ratio of 27.39, a P/E/G ratio of 3.70 and a beta of 0.45. The stock’s 50 day moving average is $169.52 and its 200 day moving average is $169.55.
Wall Street Analysts Forecast Growth
A number of equities research analysts have commented on PG shares. Morgan Stanley lifted their target price on shares of Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a research report on Monday, October 21st. Royal Bank of Canada reiterated a “sector perform” rating and set a $164.00 price objective on shares of Procter & Gamble in a research report on Monday, October 21st. Barclays cut Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 target price on the stock. in a research report on Monday, September 30th. Evercore ISI upped their price target on shares of Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a research report on Monday, October 21st. Finally, Hsbc Global Res raised shares of Procter & Gamble to a “strong-buy” rating in a report on Friday, October 4th. Eight equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, Procter & Gamble presently has a consensus rating of “Moderate Buy” and a consensus price target of $179.75.
Get Our Latest Analysis on Procter & Gamble
Insider Activity at Procter & Gamble
In other Procter & Gamble news, CEO R. Alexandra Keith sold 1,992 shares of the company’s stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $170.00, for a total value of $338,640.00. Following the transaction, the chief executive officer now directly owns 13,783 shares in the company, valued at $2,343,110. This represents a 12.63 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Gary A. Coombe sold 47,847 shares of the company’s stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the completion of the sale, the chief executive officer now directly owns 39,977 shares of the company’s stock, valued at $7,189,463.68. The trade was a 54.48 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 75,439 shares of company stock valued at $13,317,460. Insiders own 0.18% of the company’s stock.
Procter & Gamble Company Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Recommended Stories
- Five stocks we like better than Procter & Gamble
- What is a Dividend King?
- 2 Stocks to Gain From Trump Universal Tariffs on Critical Imports
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- What Are the U.K. Market Holidays? How to Invest and Trade
- Delta Can Fly to New Highs in 2025; Here’s Why
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.